ELVN Overview

Company Profile

Related stocks

PBLS • United States

Parabilis Medicines, Inc.

27.48 USD

3.39B USD

TARS • United States

Tarsus Pharmaceuticals, Inc.

73.16 USD

3.42B USD 1Y +3.5%

EWTX • United States

Edgewise Therapeutics, Inc.

39.06 USD

4.24B USD 1Y +155.6%

MRVI • United States

Maravai LifeSciences Holdings,

7.44 USD

2.76B USD 1Y +116.5%

PVLA • United States

Palvella Therapeutics, Inc.

138.77 USD

2B USD 1Y +75.5%

CELC • United States

Celcuity Inc.

67.94 USD

3.32B USD 1Y +37.1%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

MBX • United States

MBX Biosciences, Inc.

53.24 USD

2.56B USD 1Y +235.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

85.1% p.a.

Max Drawdown (5Y)

-75.6%

Sharpe Ratio (5Y)

0.22

Beta Factor

0.34

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (85.1% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -75.6% in the extended horizon.